PFSA 株価分析 — PROFUSA, INC. COMMON STOCK (Healthcare >> Medical Devices)
PFSA に関するよくある質問
PFSAのROE(自己資本利益率)は?
PROFUSA, INC. COMMON STOCKのROEは150.41%です。
PFSAの配当利回りは?
PROFUSA, INC. COMMON STOCKの配当利回りは0.00%です。
PFSAの品質スコア(Quality Score)は?
当社のAIはPFSAの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
PFSAは今が買い時ですか?
当社AIのタイミングスコアは100点中69点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
PFSAはどのセクターに属しますか?
PROFUSA, INC. COMMON STOCKはHealthcare >> Medical Devicesセクターに分類されます(NASDAQ市場)
PFSA AI Analysis Summary
Our AI summary for PFSA: PROFUSA, INC. COMMON STOCK (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of 150.41%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 69/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 1.06
Price
0.00
(0.00%)
Day Change
|
|
|---|
PFSA, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 83 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.06 |
| PBV / Sector |
-0.02 / -101.57
|
| Earning Per Share | -80.02 |
| PE / Sector |
N/A / 31.23
|
| PEG or PE/Growth / Sector |
N/A / 0.40
|
| Average 1M Daily Value |
0.77 M
GREAT
|
| Average 1W Daily Value |
1.69 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:19 |
| Symbol | PFSA |
| Name | PROFUSA, INC. COMMON STOCK |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 0.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 0.56 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 626 Bancroft Way, Berkeley, CA, United States, 94710
Phone: 925 997 6925
Website: https://profusa.com
Sector: Healthcare >> Medical Devices
Description: Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google